Actual Medicinal Product (AMP) Espranor 8mg oral lyophilisates (Pilsco Ltd)

Stability Information

Stability
not_set logo We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.
Notes
There are no stability notes available for this medicine.
Generic
Buprenorphine
Formulation
Buprenorphine 8mg oral lyophilisates sugar free
  • Buprenorphine
    • Buprenorphine 8mg oral lyophilisates sugar free

      • Espranor 8mg oral lyophilisates (Pilsco Ltd)



Related Formulations (19)

incompatible logo Buprenorphine 400microgram sublingual tablets sugar free
incompatible logo Buprenorphine 8mg sublingual tablets sugar free
incompatible logo Buprenorphine 200microgram sublingual tablets sugar free
incompatible logo Buprenorphine 2mg sublingual tablets sugar free
not_set logo Buprenorphine 10micrograms/hour transdermal patches
not_set logo Buprenorphine 20micrograms/hour transdermal patches
not_set logo Buprenorphine 52.5micrograms/hour transdermal patches
not_set logo Buprenorphine 70micrograms/hour transdermal patches
not_set logo Buprenorphine 35micrograms/hour transdermal patches
not_set logo Buprenorphine 5micrograms/hour transdermal patches
not_set logo Buprenorphine 15micrograms/hour transdermal patches
not_set logo Buprenorphine 2mg oral lyophilisates sugar free
not_set logo Buprenorphine 8mg oral lyophilisates sugar free
not_set logo Buprenorphine 25micrograms/hour transdermal patches
not_set logo Buprenorphine 30micrograms/hour transdermal patches
not_set logo Buprenorphine 40micrograms/hour transdermal patches
not_set logo Buprenorphine 1mg sublingual tablets sugar free
not_set logo Buprenorphine 4mg sublingual tablets sugar free
not_set logo Buprenorphine 6mg sublingual tablets sugar free